Trials / Completed
CompletedNCT01765491
Comparison of Two Methods of Bowel Preparation for Colonoscopy in Hospitalized Patients
Comparison of Morning-only With Split-dose Polyethylene Glycol for Colonoscopy Preparation in Hospitalized Patients: A Randomized Controlled Non-Inferiority Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Cook County Health · Other Government
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Morning-only colonoscopy preparation may improve efficiency by allowing same-day patient preparation and colonoscopy. The aim of the investigators study is to compare the efficacy and tolerability of morning-only Polyethylene Glycol (PEG) to split-dose preparation in hospitalized patients undergoing colonoscopy.
Detailed description
This is a single-center, prospective, endoscopist-blinded study in which hospitalized patients scheduled to undergo diagnostic colonoscopy were randomly assigned to receive one gallon of PEG either the morning of colonoscopy or as a split-dose (evening-morning). The primary end point is efficacy of colonoscopy preparation measured by the Ottawa scale. The investigators pre-specified a non-inferiority margin of 1.5 for the difference in Ottawa scale between arms. Secondary end points are patient compliance and tolerance. N: 120 hospitalized patients scheduled for diagnostic colonoscopy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Split-dose polyethylene glycol | Half gallon of polyethylene glycol to be taken between 7-9 pm on the day before colonoscopy and the remaining half between 7-9 am on the day of colonoscopy |
| OTHER | Morning-only polyethylene glycol | One gallon of polyethylene glycol to be taken between 5am and 9am on the day of colonoscopy |
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2012-11-01
- Completion
- 2012-12-01
- First posted
- 2013-01-10
- Last updated
- 2023-06-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01765491. Inclusion in this directory is not an endorsement.